Meanwhile, the NPPA released its list covering 543 anti-cancer drug brands.
The move could offer meaningful financial relief to cancer patients, particularly those requiring prolonged treatment.
Many cancer patients and their families know that the treatment for cancer is very expensive. This makes it hard for many patients to afford